C
알피바이오
314140KOSDAQ54.0 / 100
Reference Date: 2026-10-23
Financial Score28.5 / 40
News Sentiment12.5 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Declined 8.7% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Alpibio produces and sells pharmaceuticals (cold medicine, pain relievers) and health functional foods (omega-3, diet supplements) in various forms, including soft capsules, through OEM/ODM models. It holds over 60% of the domestic pharmaceutical soft capsule market and is rapidly growing its health functional food sales, driven by market expansion and R&D efforts with numerous patents.
Number of Employees
534people
Average Salary
37.6M KRW
Score Calculation Basis
Detailed Financial Score
PER
10.07Industry Average 15.006.5Point
Lower than industry avg (good)
PBR
0.44Industry Average 1.207.0Point
Half of industry avg (excellent)
ROE
4.47Industry Average 8.002.5Point
Below industry avg
Debt Ratio
4.34Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20254.5 / 10 points
Revenue Growth Rate
0.5 / 3
Avg ▼4.0% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲361.4% (2-year basis)
ROE Trend
1.0 / 4
Avg ROE 3.1% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (13%, downtrend)
Current 5,450Won52-week high 7,89052-week low 5,060
1-month return1.0Point
1m -8.71% (falling)
Volume trend1.0Point
Volume decreasing
Detailed Disclosure
0 totalPositive 0Neutral 0Negative 0